HTG Molecular Diagnostics, Inc. carries a market capitalization of 1.06M, placing it among publicly traded companies globally.
| Market Cap | 1.06M |
| Enterprise Value | N/A |
HTG Molecular Diagnostics, Inc.'s stock has declined approximately -97.8022% over the past 52 weeks. The 50-day moving average sits at 2.33, while the 200-day moving average is 4.75.
| Beta (5Y) | N/A |
| 52-Week Price Change | -97.8022% |
| 50-Day Moving Average | 2.33 |
| 200-Day Moving Average | 4.75 |
| Average Volume (20 Days) | N/A |
HTG Molecular Diagnostics, Inc.'s most recent stock split took place on December 21, 2022 with a 12:1 split ratio.
| Last Split Date | 12/21/2022 |
| Split Ratio | 12:1 |